First CD79b Targeted Therapy! Roche Antibody Drug Conjugate Polatuzumab Vedotin is Given Priority Review by FDA in the United States

Swiss pharmaceutical giant Roche recently announced that the Food and Drug Administration (FDA) has accepted the biologics licensing application (BLA) of polatuzumab vedotin, antibody drug conjugate (ADC), and granted priority review. TheRead More…

The World’s First Nanobody Drug! Sanofi Cablivi is Approved by FDA for the Treatment of Rare Thrombotic Diseases

French pharmaceutical giant Sanofi recently announced that the US Food and Drug Administration (FDA) has approved the nanobody drug Cablivi (caplacizumab), combined with plasma exchange and immunosuppressive therapy. For the treatment ofRead More…

Common Engineering Techniques and Strategies in Antibody Discovery

In the process of discovering monoclonal antibodies, after screening antibody libraries to obtain excellent candidate molecules that can specifically bind to targets, it is necessary to enhance certain pharmacological and other functionsRead More…